Supreme Reports Granting of Options

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 14, 2014) - Supreme Pharmaceuticals Inc. (OTCBB:SPRWF) (CSE:SL) announced today that it has issued 4,100,000 stock options to directors, officers, employees and consultants. Each option entitles the holder to acquire one common share of the Company for a period of five years (3,900,000 options) or two years (200,000 options), at a price of $0.41 per share. These options were issued in accordance with the Company's incentive stock option plan.